Top Markets
#1 Velas Velas +367.73%
#2 Gravity Gravity +49.99%
#3 Galxe Galxe +35.17%
#4 Derive Derive +31.29%
#5 Infinity Ground Infinity Ground +29.18%
#6 Wiki Cat Wiki Cat +25.33%
#7 Audiera Audiera +24.94%
#8 Fuzzybear Fuzzybear +22.68%
#9 Fetch.ai Fetch.ai +22.26%
#10 Wrapped QUIL Wrapped QUIL +21.56%
Coin of the day
Velas Velas
Setări
Limbă
ROMâNă
Monedă
USD
Temă
MultiCell Technologies, Inc. MultiCell Technologies, Inc.

MultiCell Technologies, Inc.

MCET
Rang în acțiuni #20716
MultiCell Technologies, Inc., a biopharmaceutical company, develops novel... MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc. in April 2004. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island.
Preț acțiune
$0.00001
Capitalizare de piață
$50.01K
Schimbare (1 zi)
0.00%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează MultiCell Technologies, Inc. (MCET)

Categorie

Healthcare
Capitalizare de piață
Venituri
mai mult
Profituri
Istoric prețuri
Raport P/E
Raport P/S
Raport P/B
Marjă operațională
EPS
Divizări de acțiuni
Dividende
Randament dividend
Acțiuni în circulație
EPS pentru MultiCell Technologies, Inc. (MCET)
EPS la data de August 2015 TTM: $0.00
Conform celor mai recente rapoarte financiare și prețului acțiunilor MultiCell Technologies, Inc., EPS-ul actual al companiei (TTM) este $0.00. La sfârșitul anului 2013, compania avea un EPS de $0.00 egal cu EPS-ului din 2026, care a fost de 0.
Istoricul EPS pentru MultiCell Technologies, Inc. din 2013 până în 2026
EPS la sfârșitul fiecărui an
An EPS Schimbă
2026 (TTM) 0.00 -83.33%
2014 0.00 -83.33%
2013 0.00 0.00%
EPS pentru companii similare sau concurente
Companie EPS Diferență EPS Țara
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $3.62 134,059.26%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $15.47 572,862.96%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $43.12 1,596,937.04%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $9.62 356,225.93%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 110,270.37%
AU